Cargando…

Reply to “The outbreak of COVID-19: An overview”

Detalles Bibliográficos
Autores principales:	Wu, Yi-Chi, Chen, Ching-Sung, Chan, Yu-Jiun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199775/ https://www.ncbi.nlm.nih.gov/pubmed/32502121 http://dx.doi.org/10.1097/JCMA.0000000000000331

Ejemplares similares

The outbreak of COVID-19: An overview
por: Wu, Yi-Chi, et al.
Publicado: (2020)

Author's Reply to Heart Transplantation to Fulminant Myocarditis during COVID-19 Outbreak
por: Kim, In-Cheol, et al.
Publicado: (2020)

In Reply: Hormones and COVID-19
por: Park, Myung S., et al.
Publicado: (2023)

In Reply to the “Letter to the Editor Regarding Telemedicine in Neurosurgery During the COVID-19 Outbreak: Where We Are 1 Year Later”
por: Mouchtouris, Nikolaos, et al.
Publicado: (2022)

Reply to “Novaferon, treatment in COVID-19 patients”
por: Zheng, Fang, et al.
Publicado: (2021)

Reply: CPET for Long COVID-19
por: Mancini, Donna M., et al.
Publicado: (2022)

Reply to the syndemic of “COVID-19 and tuberculosis”
por: Patil, Rajashri A., et al.
Publicado: (2023)

Authors' reply
por: Li, Allen, et al.
Publicado: (2008)

In Reply
por: Fathi, Amir T., et al.
Publicado: (2016)

Reply
por: Kwon, Young Sam, et al.
Publicado: (2004)

Plasma hemoglobin in COVID-19: authors’ reply
por: Lancman, Guido, et al.
Publicado: (2020)

In reply—The “Perfect Cytokine Storm” of COVID-19
por: Vijayvargiya, Prakhar, et al.
Publicado: (2020)

Reply To: Response to COVID-19 by the surgical community
por: Chapman, Robert
Publicado: (2020)

Type and dose of heparin in Covid‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

Reply to Comment on “Osteoporosis in the Age of COVID-19”
por: Girgis, C. M., et al.
Publicado: (2021)

Reply to “Pulmonary toxicity by oxygen and COVID-19”()
por: Belenguer-Muncharaz, A., et al.
Publicado: (2022)

Reply to: “Liver tests abnormalities in COVID-19: trick or treat?”
por: Cai, Qingxian, et al.
Publicado: (2020)

Author’s reply
por: Park, Chan Hong
Publicado: (2019)

Author's Reply to Systemic Inflammation in the Setting of Cardiac Myxomas: an Overview of Clinical and Practical Considerations
por: Yoon, Ji Hong, et al.
Publicado: (2021)

Reply to the letter concerning Kawasaki disease and Covid-19
por: Loomba, Rohit S., et al.
Publicado: (2020)

DOACs and “newer” hemophilia therapies in COVID‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

'Post-COVID-19 chronic symptoms' – Author's reply
por: Davido, Benjamin, et al.
Publicado: (2021)

‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply
por: Wooding, Denise J., et al.
Publicado: (2021)

Reply to “Consensus document on tracheotomy in patients with COVID-19”()
por: Martín Delgado, M.C., et al.
Publicado: (2021)

Reply to: Trajectories of vital signs in patients with Covid-19
por: Redfern, Oliver C., et al.
Publicado: (2021)

Reply to Consensus document on tracheotomy in patients with COVID 19()
por: Pérez Acosta, G., et al.
Publicado: (2021)

In reply—COVID-19: Precision Medicine and Vascular Endothelium
por: Cresci, Sharon, et al.
Publicado: (2021)

Reply to “Impact of COVID-19 on the mental health of radiologists”
por: Demirjian, Natalie L., et al.
Publicado: (2021)

Reply to professionally responsible COVID-19 vaccination counseling
por: Chervenak, Frank A., et al.
Publicado: (2021)

In Reply—How Safe Is COVID-19 Convalescent Plasma?
por: Joyner, Michael J., et al.
Publicado: (2021)

“ISTH guidelines for antithrombotic treatment in COVID‐19”: Reply
por: Schulman, Sam, et al.
Publicado: (2022)

Reply to “Tachycardia, adverse effect, COVID-19 vaccine”
por: Teresa Marco García, M., et al.
Publicado: (2023)

Reply to: “Clinical characteristics of COVID-19 patients with abnormal liver tests”
por: Cai, Qingxian, et al.
Publicado: (2020)

Reply
por: Zhang, Yi, et al.
Publicado: (2019)

Author's reply
por: Wu, Jun-Song, et al.
Publicado: (2013)

Author`s Reply
por: Yao, Mingyang, et al.
Publicado: (2019)

China shares experience during the COVID-19 outbreak
por: Xu, Zhao, et al.
Publicado: (2021)

Reply: Iron chelation may harm patients with COVID-19
por: Abobaker, Anis
Publicado: (2020)

Authors’ Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19
por: Liu, Bin, et al.
Publicado: (2020)

Reply to: Cadaverless anatomy: Darkness in the times of pandemic Covid-19
por: Murlimanju, B.V., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6j8gq6rggc5mbvoenm30pmi6lu